Is a biopsy recommended for a patient with suspected pheochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Biopsy of Pheochromocytoma: Not Recommended

Biopsy of suspected pheochromocytoma is contraindicated due to the high risk of triggering a potentially fatal hypertensive crisis. 1

Diagnostic Approach for Suspected Pheochromocytoma

The proper diagnostic approach for pheochromocytoma follows a specific sequence:

  1. Biochemical confirmation first

    • Plasma free metanephrines is the preferred initial test (99% sensitivity, 89% specificity) 1, 2
    • 24-hour urine collection for fractionated metanephrines is an alternative (97% sensitivity) 1, 2
    • Levels typically >4 times the upper limit of normal in true pheochromocytoma 1
  2. Imaging only after biochemical confirmation

    • MRI is preferred over CT if pheochromocytoma is strongly suspected due to risk of hypertensive crisis with IV contrast 1
    • Adrenal protocol CT or MRI should be performed to evaluate for adrenal masses 1
    • Whole-body imaging from skull base to pelvis for suspected paraganglioma 1
  3. Additional functional imaging if needed

    • Meta-iodobenzylguanidine (MIBG) scintigraphy if conventional imaging is negative 1
    • FDOPA-PET for detection of pheochromocytomas in hereditary syndromes 1

Why Biopsy is Dangerous

Pheochromocytomas are highly vascular tumors that secrete catecholamines. Manipulation during biopsy can trigger:

  • Massive catecholamine release leading to hypertensive crisis
  • Potentially fatal arrhythmias
  • Stroke or myocardial infarction
  • Tumor rupture and seeding

Clinical Presentation to Consider

Pheochromocytoma should be suspected in patients with:

  • Paroxysmal hypertension (may be sustained in up to 50% of cases) 3
  • Classic triad: headaches, palpitations, and sweating 1
  • Resistant hypertension (prevalence up to 4% in referred RH patients) 3
  • Family history of pheochromocytoma or related genetic syndromes 1
  • Incidentally discovered adrenal mass

Preoperative Management

Once diagnosed, proper preparation before surgical removal includes:

  • Alpha-adrenergic blockade should be started if normetanephrine levels are ≥2-fold the upper reference limit 1
  • Options include:
    • Non-selective α-blocker: Phenoxybenzamine (40-80 mg/day)
    • Selective α1-blockers: Doxazosin, prazosin, or terazosin 1
  • Beta-blockers should only be added after adequate alpha-blockade 1
  • Calcium channel blockers can be added if target blood pressure is not achieved 1

Surgical Approach

  • Complete surgical resection is the definitive treatment 1
  • Laparoscopic adrenalectomy for small tumors (<8 cm) without invasion
  • Open surgery for larger tumors (>5-6 cm) or with evidence of invasion 1
  • Surgery should be performed in specialized centers with experience in adrenalectomy 1

Key Pitfalls to Avoid

  1. Never perform a biopsy of suspected pheochromocytoma
  2. Never proceed to imaging without biochemical confirmation first
  3. Never start beta-blockers before adequate alpha blockade (can worsen hypertension)
  4. Never miss genetic testing (approximately 40% of cases are hereditary) 4, 5
  5. Never discharge without planning lifelong follow-up (recurrences can occur decades later) 6

The diagnostic approach to pheochromocytoma requires careful sequencing of tests, with biochemical confirmation always preceding any invasive procedures. Biopsy should be avoided entirely due to the significant risk of triggering a potentially fatal hypertensive crisis.

References

Guideline

Treatment of Pheochromocytoma and Paraganglioma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pheochromocytoma. Preoperative approach.

Medicina clinica, 2024

Research

Pheochromocytoma.

Endocrine regulations, 2019

Research

Pheochromocytoma. Update on diagnosis, localization, and management.

The Medical clinics of North America, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.